mRNA |
Axitinib |
FIMM |
pan-cancer |
AAC |
-0.33 |
0.04 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.097 |
0.04 |
mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
0.073 |
0.04 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.04 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.04 |
mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.04 |
mRNA |
STF-62247 |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.04 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.04 |
mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
-0.088 |
0.04 |
mRNA |
Imatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.04 |